Current Best Practices for Anxiety Management: Biopsychosocial, Cognitive-Behavioral, and Pharmacological Approaches

This podcast episode, presented by Dr. Dawn Elise Snipes, delves into current best practices for treating anxiety, drawing on research from the past five years. It emphasizes a holistic, biopsychosocial approach, recognizing that anxiety stems from a complex interplay of biological, psychological, and social factors. The discussion highlights common causes and triggers for anxiety, such as abandonment issues, low self-esteem, irrational thoughts, fear of the unknown, loss, job insecurity, safety concerns, shattered dreams, and phobias. A key argument is that effective treatment requires understanding these underlying causes, as anxiety stemming from physical symptoms (like a racing heart) necessitates a different approach than anxiety rooted in psychological issues (like abandonment trauma).\n\nThe episode makes crucial distinctions regarding the nature and impact of anxiety. It explains how chronic anxiety can lead to depression due to the body's depletion of excitatory neurotransmitters and the brain's perception of hopelessness. Anxiety is also identified as a major trigger for addiction relapse, a contributor to increased physical pain (due to serotonin's role as a pain modulator), and a cause of poor sleep quality. The concept of comorbidity is central, stressing that anxiety rarely presents as a standalone diagnosis but often co-occurs with depression, substance use disorders, and physical ailments. Genetic vulnerability is introduced as a significant factor influencing an individual's susceptibility to anxiety, their response to stress, their likelihood of substance dependence, and the efficacy of different medications.\n\nPractical insights and recommendations for clinicians and clients are abundant. Dr. Snipes advocates for a comprehensive assessment that considers childhood adversity, trauma, current stressors, and the availability of social support. She advises ruling out physical causes for anxiety symptoms, such as hormone imbalances or heart conditions, before solely focusing on psychological interventions. For pharmacological treatment, the episode reviews first-line drugs like SSRIs and SNRIs, noting that counseling combined with pharmacotherapy generally yields the best outcomes. A significant caution is raised regarding benzodiazepines, highlighting their high dependence risk, increased mortality rate, and correlation with long-term dementia, especially with daily, prolonged use. Genetic testing is suggested for clients struggling to find an effective medication regimen, and the importance of continuing medication for 6-12 months post-remission is stressed.\n\nBroader implications include understanding anxiety's pervasive impact on overall quality of life, from physical well-being to social functioning. The cultural emphasis on success and perfectionism is identified as a societal factor contributing to anxiety around failure. The discussion underscores the dynamic nature of mental health, where past traumas can have lasting effects on current cognitions and emotional responses, and where genetic predispositions interact with environmental factors. Ultimately, the episode champions an informed, empathetic, and multi-faceted approach to anxiety management, empowering both clinicians to provide comprehensive care and clients to navigate their journey toward improved well-being." "concepts": [ "Biopsychosocial approach

anxiety that's caused by for example somebody having a racing heart may be different than anxiety that's caused for somebody who has abandonment issues so we're gonna treat the two things differently

low-grade chronic stress and anxiety arose energy and people's ability to concentrate

anxiety is a major trigger for addiction relapse

serotonin which is one of our major anti-anxiety neurotransmitters is also one of our major pain modulators

irrational thoughts and cognitive distortions may lead people to believe that if I'm not perfect for example I am not lovable

when people have panic attacks for example they truly think they're having a heart attack

anxiety depression and substance disorders as well as a range of physical disorders are often comorbid

behavioral therapy is regarded as the psychotherapy with the highest level of evidence

counseling Plus pharmacotherapy tends to have the best outcomes

there are at least four different genetic variations which are correlated with the development of generalized anxiety disorder

there's a higher mortality rate among benzo users compared with non-users

there's also an increased risk of dementia identified in long-term benzodiazepine users